Guideline Summary for Amlodipine (Calcium‑Channel‑Blocker) Overdose Management in Polysubstance Toxicity

Cardiovascular Assessment

• Obtain an immediate 12‑lead ECG and initiate continuous cardiac telemetry to detect QRS prolongation, bradycardia, hypotension, and other conduction abnormalities caused by amlodipine toxicity. 1, 2
• Measure blood pressure frequently; amlodipine produces profound peripheral vasodilation and hypotension with prolonged duration owing to its long half‑life. 1, 3
• Establish large‑bore intravenous access for aggressive fluid resuscitation and rapid medication delivery. 2

Pharmacologic Management of Hypotension

• Start norepinephrine as the preferred vasopressor for amlodipine‑induced hypotension; adult doses may need to be titrated up to ≈ 100 µg/min. 1, 2
• Initiate high‑dose insulin therapy for hypotension refractory to vasopressors – a Class I (strong) recommendation with the highest level of evidence for calcium‑channel‑blocker poisoning. Typical adult regimen: insulin 1 U/kg IV bolus, then continuous infusion 0.5–1 U/kg/h (titrate up to ≈ 10 U/kg/h). 1, 3
• Give an initial dextrose bolus (≈ 25–50 g) concomitantly with insulin and maintain a continuous dextrose infusion (e.g., D10W or D5W at 100–200 mL/h) to keep glucose ≈ 100–200 mg/dL; monitor glucose every 15–30 min initially, then hourly. 1
• Monitor serum potassium closely and replace aggressively, as high‑dose insulin frequently induces hypokalemia. 2, 3

Adjunctive Calcium Therapy

• Administer intravenous calcium gluconate 3–6 g (30–60 mL of 10 % solution) over 5–10 min; repeat every 15–20 min as needed. 1, 2
• Target ionized calcium levels up to twice the normal range to enhance therapeutic effect. 2, 4
• Calcium alone is seldom sufficient; most patients will still require vasopressors and high‑dose insulin. 4

Bradycardia Management

• Give atropine 0.5–1 mg IV for hemodynamically significant bradycardia, recognizing that treatment failures are common. 1, 2
• Consider glucagon 3–5 mg IV bolus followed by infusion 2–10 mg/h for refractory bradycardia; evidence is uncertain. 1, 2
• Electrical pacing may be attempted for refractory bradycardia but is often ineffective, especially when complete AV‑node blockade or severe vasodilatory shock is present. 2, 4

Refractory Shock (Cardiogenic)

• Early consideration of veno‑arterial extracorporeal membrane oxygenation (VA‑ECMO) is advised for shock unresponsive to maximal pharmacologic therapy; reported survival approaches ≈ 77 %. 1, 2, 4
• Intravenous lipid emulsion (ILE) should not be used routinely for calcium‑channel‑blocker poisoning, as it may increase gastrointestinal absorption of lipophilic agents and worsen toxicity. 1, 2, 3

Contraindicated Interventions for Co‑ingestants

• Do not administer flumazenil in mixed overdoses involving zolpidem, ethanol, or other CNS depressants because it can precipitate seizures. 5, 6, 7

Supportive Care for Other Substances

• Gabapentin contributes to central nervous system depression; primary management is supportive care with vigilant respiratory monitoring. 5
• Promethazine adds anticholinergic toxicity; monitor for urinary retention, tachycardia, hyperthermia, and altered mental status. 7
• Physostigmine is rarely indicated and should be reserved for severe, isolated anticholinergic toxicity. 4

Seizure Management

• First‑line therapy for seizures is a benzodiazepine (lorazepam 2–4 mg IV or diazepam 5–10 mg IV); repeat dosing every 5–10 min as needed. 7

Monitoring and Laboratory Evaluation

• Obtain baseline and serial metabolic panels (electrolytes, renal function, glucose) and ionized calcium measurements. 1, 2, 4
• Measure creatine kinase serially when prolonged immobilization is suspected. 4
• Maintain continuous cardiac telemetry for at least 6 hours in symptomatic patients. 7
• Perform serial ECGs to track QRS duration and conduction changes. 7
• Record vital signs every 15 minutes initially, then hourly once the patient stabilizes. 4

ICU Admission Criteria

• Admit to the intensive care unit if any of the following are present:

Key Clinical Pearls (Avoidable Errors)

• Do not delay high‑dose insulin therapy; it is the most effective intervention for amlodipine‑induced hypotension and should be started early alongside vasopressors. 1, 3
• Do not underestimate the prolonged effect of amlodipine; toxicity may persist for 24–48 hours, necessitating extended monitoring. 1, 3
• Do not use flumazenil in polysubstance overdoses because of heightened seizure risk. 5, 6, 7
• Do not employ intravenous lipid emulsion for calcium‑channel‑blocker poisoning, as it may aggravate toxicity. 1, 2, 3

Management of Amlodipine Overdose – Evidence‑Based Recommendations

Immediate Pharmacologic Management

• Norepinephrine should be started immediately as the preferred vasopressor for amlodipine‑induced hypotension, with titration up to roughly 100 µg/min in adults (Class I recommendation) [8][9].
• Epinephrine may be added or substituted when additional inotropic support is required (Class I recommendation) 10.
• High‑dose insulin therapy is recommended early for hypotension, either alongside or when refractory to vasopressors; this carries the strongest supporting evidence (Class I, Level B‑NR) [8][9]10.
• High‑dose insulin improves myocardial contractility and is associated with fewer vasoconstrictive complications compared with vasopressor‑only regimens (Class I) [9][11].
• Serum potassium should be monitored closely and aggressively replaced during high‑dose insulin therapy because hypokalemia is common (Class I) 9.

Intravenous Calcium Therapy

• Calcium gluconate 3–6 g (30–60 mL of 10 % solution) administered IV over 5–10 min, repeatable every 15–20 min as needed (Class I) [9][10].
• Target ionized calcium levels up to twice the normal range to maximize therapeutic effect (Class I) [9][11].
• Calcium alone is rarely sufficient; most patients will still require vasopressors and high‑dose insulin (Class I) [11][10].

Management of Bradycardia

• Atropine 0.5–1 mg IV is advised for hemodynamically significant bradycardia, although treatment failures are common (Class I) [9][11].
• Glucagon 3–5 mg IV bolus followed by an infusion of 2–10 mg/h may be used for refractory bradycardia; response rates are variable and vomiting is frequent (Class I) [9][11].
• Electrical pacing can be attempted for refractory bradycardia but is often ineffective, especially with complete AV‑node block or severe vasodilatory shock (Class I) [9][11].

Refractory Shock Management

• Veno‑arterial extracorporeal membrane oxygenation (VA‑ECMO) should be considered early for shock unresponsive to maximal pharmacologic therapy; reported survival approaches 77 % (Class IIa) [9][11]10.
• VA‑ECMO is lifesaving for persistent cardiogenic (pump‑failure) shock that does not respond to maximal supportive care (Class IIa) [9][11].

Adjunctive Therapies for Refractory Vasodilatory Shock

• Methylene blue may be used as an adjunct in refractory vasodilatory shock, though clinical responses are mixed and often transient (Class IIb) [9][11].

Contraindicated Therapy

• Intravenous lipid emulsion (ILE) is not recommended for calcium‑channel‑blocker poisoning, as it can increase gastrointestinal absorption of lipophilic agents like amlodipine and worsen toxicity (Class III, No Benefit) 11.
• A large retrospective study found no clinical benefit from ILE therapy in CCB poisoning (Class III, No Benefit) [9][11].

Decontamination

• Activated charcoal may be administered for asymptomatic patients who present within 1–2 hours of a potentially toxic ingestion (Class I) 10.

Management of Amlodipine Overdose

Initial Pharmacologic Management

• High‑dose insulin therapy combined with vasopressors (primarily norepinephrine) is the cornerstone of treatment for amlodipine overdose‑related hypotension and should be started early rather than reserved for refractory cases (Class I recommendation, strong evidence). [12][13]

• Calcium gluconate 3–6 g IV administered over 5–10 min, repeatable every 15–20 min as needed, is recommended, but calcium alone is rarely sufficient; most patients will still require vasopressors and high‑dose insulin. (Class IIa, moderate evidence) 12

Vasopressor Therapy

• Norepinephrine is the preferred first‑line vasopressor for amlodipine‑induced hypotension in adults, titrated up to approximately 100 µg/min as required. (Class I, strong evidence) [12][13]
• The 2025 American Heart Association (AHA) guidelines report excellent survival rates with primary norepinephrine use and low rates of ischemic complications despite high doses. (Class I) 12

High‑Dose Insulin Therapy

• Insulin 1 U/kg IV bolus followed by a continuous infusion starting at 0.5–1 U/kg/h, titrated up to ≈10 U/kg/h, improves myocardial contractility and is associated with fewer vasoconstrictive complications compared with vasopressor‑only regimens. (Class I, strong evidence) 12
• Serum potassium must be monitored closely and replaced aggressively because hypokalaemia is common and potentially dangerous during high‑dose insulin therapy. (Class I) [12][13]
• Protocolized insulin‑glucose‑potassium management reduces the risk of hypoglycaemia. (Class I) 12

Bradycardia Management

• Atropine 0.5–1 mg IV is advised for hemodynamically significant bradycardia, although treatment failures are common. (Class IIa) 12
• Glucagon 3–5 mg IV bolus followed by an infusion of 2–10 mg/h may be used for refractory bradycardia; response rates are variable and vomiting is frequent. (Class IIa) 12
• Electrical pacing can be attempted for refractory bradycardia but is often ineffective, especially with complete AV‑node block or severe vasodilatory shock. (Class IIb) 12

Refractory Shock and Mechanical Support

• Veno‑arterial extracorporeal membrane oxygenation (VA‑ECMO) should be considered early for shock unresponsive to maximal pharmacologic therapy; reported survival approaches 77 %. (Class IIa, moderate evidence) [12][13]
• The 2025 AHA guidelines give a Class IIa recommendation for extracorporeal life support (ECLS) in calcium‑channel‑blocker poisoning with cardiogenic shock refractory to pharmacologic interventions. [12][13]
• Methylene blue, a nitric‑oxide‑synthase inhibitor, may be used as an adjunct in refractory vasodilatory shock, though clinical responses are mixed and often transient. (Class IIb) 12

Contraindicated Therapy

• Intravenous lipid emulsion (ILE) should NOT be used for calcium‑channel‑blocker poisoning (Class III, no benefit). ILE can increase gastrointestinal absorption of lipophilic agents like amlodipine and worsen toxicity. (Class III) 12

Monitoring and Clinical Considerations

• Do not delay high‑dose insulin therapy—it is the most effective intervention and should be initiated early alongside vasopressors. (Class I) [12][13]
• Amlodipine toxicity may persist for 24–48 h because of its long half‑life (30–50 h), necessitating extended hemodynamic and ECG monitoring. (Class I) 12
• Monitor for volume overload as a complication of high‑dose insulin therapy. (Class I) [12][13]
• Amlodipine causes profound vasodilation mediated by nitric‑oxide release, explaining why dihydropyridine toxicity often requires more vasopressor support than non‑dihydropyridine calcium‑channel blockers. (Class I) [12][13]